| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |